Cargando…

FOXO1 inactivation induces cisplatin resistance in bladder cancer

We found that FOXO1‐shRNA sublines or FOXO1‐positive cells co–treated with a FOXO1 inhibitor were significantly more resistant to cisplatin treatment at pharmacological concentrations, compared with respective control sublines or those with mock treatment. Western blot demonstrated considerable incr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ide, Hiroki, Goto, Takuro, Teramoto, Yuki, Mizushima, Taichi, Jiang, Guiyang, Nagata, Yujiro, Inoue, Satoshi, Baras, Alexander S., Kashiwagi, Eiji, Miyamoto, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469822/ https://www.ncbi.nlm.nih.gov/pubmed/32678492 http://dx.doi.org/10.1111/cas.14557

Ejemplares similares

Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer
por: Jiang, Guiyang, et al.
Publicado: (2021)

Androgen Receptor Signaling Induces Cisplatin Resistance via Down-Regulating GULP1 Expression in Bladder Cancer
por: Teramoto, Yuki, et al.
Publicado: (2021)

ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signaling
por: Inoue, Satoshi, et al.
Publicado: (2018)

Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression
por: Kashiwagi, Eiji, et al.
Publicado: (2018)

Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer
por: Kashiwagi, Eiji, et al.
Publicado: (2016)

ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion
por: Kawahara, Takashi, et al.
Publicado: (2016)

The interaction between androgen receptor and semenogelin I: a synthetic LxxLL peptide antagonist inhibits the growth of prostate cancer cells
por: Li, Peng, et al.
Publicado: (2018)

GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer
por: Elahi Najafi, Mohammad Amin, et al.
Publicado: (2023)

Expression of Phospho-ELK1 and Its Prognostic Significance in Urothelial Carcinoma of the Upper Urinary Tract
por: Inoue, Satoshi, et al.
Publicado: (2018)

The Role of Glucocorticoid Receptor Signaling in Bladder Cancer Progression
por: Ide, Hiroki, et al.
Publicado: (2018)

Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: A meta-analysis of immunohistochemical studies
por: Ide, Hiroki, et al.
Publicado: (2017)

NFATc1 Expression as a Prognosticator in Urothelial Carcinoma of the Upper Urinary Tract
por: Kawahara, Takashi, et al.
Publicado: (2017)

Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1
por: Kawahara, Takashi, et al.
Publicado: (2015)

ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression
por: Kawahara, Takashi, et al.
Publicado: (2015)

Sex Hormone Receptor Signaling in Bladder Cancer: A Potential Target for Enhancing the Efficacy of Conventional Non-Surgical Therapy
por: Ide, Hiroki, et al.
Publicado: (2021)

The Role of Androgen Receptor Signaling in Ovarian Cancer
por: Mizushima, Taichi, et al.
Publicado: (2019)

The impact of perivesical lymph node metastasis on clinical outcomes of bladder cancer patients undergoing radical cystectomy
por: Sharma, Meenal, et al.
Publicado: (2019)

Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies
por: Kita, Yuki, et al.
Publicado: (2019)

Bcl2 Deficiency Activates FoxO through Akt Inactivation and Accelerates Osteoblast Differentiation
por: Moriishi, Takeshi, et al.
Publicado: (2014)

Cordycepin Resensitizes T24R2 Cisplatin-Resistant Human Bladder Cancer Cells to Cisplatin by Inactivating Ets-1 Dependent MDR1 Transcription
por: Oh, Sang-Seok, et al.
Publicado: (2020)

Evolutionary inactivation of a sialidase in group B Streptococcus
por: Yamaguchi, Masaya, et al.
Publicado: (2016)

The prognostic role of steroid hormone receptor signaling pathways in urothelial carcinoma
por: Nagata, Yujiro, et al.
Publicado: (2020)

Results of second transurethral resection for high-grade T1 bladder cancer
por: Hashine, Katsuyoshi, et al.
Publicado: (2016)

Expression level of dihydropyrimidine dehydrogenase is associated with clinical outcome in patients with T1G3 bladder cancer treated with Bacillus Calmette-Guerin
por: Ide, Hiroki, et al.
Publicado: (2014)

Silibinin Alleviates Muscle Atrophy Caused by Oxidative Stress Induced by Cisplatin through ERK/FoxO and JNK/FoxO Pathways
por: Chi, Meng-yi, et al.
Publicado: (2022)

Higher expression of FOXOs correlates to better prognosis of bladder cancer
por: Zhang, Ying, et al.
Publicado: (2017)

Bladder urothelial carcinoma producing insulin‐like growth factor II: A case report
por: Funada, Satoshi, et al.
Publicado: (2018)

Therapeutic enhancement of S-1 with CPT-11 through down-regulation of thymidylate synthase in bladder cancer
por: Ide, Hiroki, et al.
Publicado: (2013)

Inactivation of FOXO1 induces T follicular cell polarization and involves angioimmunoblastic T cell lymphoma
por: Xu, Meifang, et al.
Publicado: (2019)

Circular RNA FOXO3 accelerates glycolysis and improves cisplatin sensitivity in lung cancer cells via the miR-543/Foxo3 axis
por: Zhang, Yanni, et al.
Publicado: (2021)

CD226 regulates natural killer cell antitumor responses via phosphorylation-mediated inactivation of transcription factor FOXO1
por: Du, Xiangnan, et al.
Publicado: (2018)

Clinical course involving thrombocytosis and thrombocytopenia in a patient with bladder cancer treated with gemcitabine and cisplatin
por: Watanabe, Ayako, et al.
Publicado: (2021)

The Role of Estrogen Receptors in Urothelial Cancer
por: Goto, Takuro, et al.
Publicado: (2021)

ICOS Coreceptor Signaling Inactivates the Transcription Factor FOXO1 to Promote Tfh Cell Differentiation
por: Stone, Erica L., et al.
Publicado: (2015)

Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER
por: Zekas, Erin, et al.
Publicado: (2015)

Erratum to Inactivation of FOXO1 induces T follicular cell polarization and involves angioimmunoblastic T cell lymphoma
por: Xu, Meifang, et al.
Publicado: (2020)

Linalool Prevents Cisplatin Induced Muscle Atrophy by Regulating IGF-1/Akt/FoxO Pathway
por: Zhang, Hong, et al.
Publicado: (2020)

The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma
por: Niu, Jianfang, et al.
Publicado: (2022)

The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder
por: Baras, Alexander S., et al.
Publicado: (2016)

Steroid Hormone Receptor Signals as Prognosticators for Urothelial Tumor
por: Ide, Hiroki, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_343b2ji9njij6vvt640obdp91e